Park Nicollet Institute is a clinical research site located in Minneapolis, Minnesota, United States 55416.
Crixeo Clinical Trials Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Park Nicollet Institute has participated in 7 clinical trials.
Therapeutic areas: Breast Cancer, Asthma, Diabetes Mellitus, Type 2.
Sponsors: Eisai Inc., Amphastar Pharmaceuticals, Inc., Boehringer Ingelheim.
Trust Score: 73/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Park Nicollet Institute has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Park Nicollet Institute has 7 clinical trials on record. Their work covers Breast Cancer, Asthma, Diabetes Mellitus, Type 2.
Park Nicollet Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.